Radiolabeled monoclonal antibody (unspecified in title)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Radiolabeled monoclonal antibody (unspecified in title), covering 2015-12-17 to 2015-12-17. Get the full timeline:
Most recent: Clinical Trial Update: Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1, Phase 2]